Tech Company Financing Transactions
Vima Therapeutics Funding Round
Vima Therapeutics closed a $40 million Series A venture capital round on 3/11/2026. Backers included Access Industries, Atlas Venture and Canaan Partners.
Transaction Overview
Company Name
Announced On
3/11/2026
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series A
Proceeds Purpose
The financing will enable the company to complete two Phase 2 trials with VIM0423 for isolated dystonia and Parkinson's disease.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Undisclosed
Cambridge, MA Undisclosed
USA
Cambridge, MA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
We are a team of doctors, scientists, and experts in movement disorders, with decades of experience developing treatments for neurological diseases. We are proud to bring a first-in-class oral medicine to people suffering with dystonia.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bernard Ravina
Browse more venture capital transactions:
Prev: 3/11/2026: Bliss venture capital transaction
Next: 3/11/2026: AquaExchange venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs